(NC5505) Radiosurgery Is Ticky, but Works…indications, Limitations and Long-term Outcomes

Monday, April 24, 2023

8:59am – 9:15am PST

Location: Los Angeles Convention Center, 411- Theater

Speaker(s)

Clark C. Chen, MD, PhD

Chair
University of Minnesota
Minneapolis, Minnesota, United States

Moderator(s)

Gordon Li, MD

Professor and Vice Chair, Faculty Affairs
Stanford University Department of Neurosurgery
Stanford, California, United States
Chetan Bettegowda, MD, PhD (he/him/his)

Professor and Vice Chair
Johns Hopkins
Baltimore, Maryland, United States

Disclosure(s):

Clark C. Chen, MD, PhD: Clearpoint Neuro: Consultant (Ongoing); Medtronic: Consultant (Ongoing)

Gordon Li, MD: Abbott: Stock Shareholder (excluding mutual funds) (Ongoing); Biogen: Stock Shareholder (excluding mutual funds) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Bristol Myers Squibb: Grant/Research Support (Terminated, February 6, 2023); gilead: Stock Shareholder (excluding mutual funds) (Ongoing); J&J/Synthes: Speaker/Honoraria (Terminated, February 6, 2023); Medtronic: Consultant (Ongoing); Merck: Stock Shareholder (excluding mutual funds) (Ongoing); Novocure: Grant/Research Support (Ongoing); Pfizer: Stock Shareholder (excluding mutual funds) (Ongoing); Photonic Medical: Advisor (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); stryker: Stock Shareholder (excluding mutual funds) (Ongoing)

Chetan Bettegowda, MD, PhD: Belay Diagnostics: Board Member/Officer/Trustee (Ongoing), Ownership Interest (Ongoing); Bionaut Labs: Consultant (Ongoing); Depuy-Synthes: Consultant (Ongoing); Galectin Therapeutics: Consultant (Ongoing); Haystack Oncology: Consultant (Ongoing); OrisDx: Board Member/Officer/Trustee (Ongoing), Ownership Interest (Ongoing); Privo Technology: Consultant (Ongoing)